Skip to main content

Table 3 Differences in patients’ clinicopathological features between the symptomatic and asymptomatic groups

From: Subjective factors affecting prognosis of 469 patients with esophageal squamous cell carcinoma: a retrospective cohort study of endoscopic screening

 

Asymptomatic group (n = 129)

Symptomatic group (n = 270)

P value

Age

67.9 ± 8.99

68.8 ± 9.19

0.368

Sex (men) (%)

107 (82.9%)

221 (81.9%)

0.889

Alcohol drinking (%)

113 (87.6%)

222 (83.5%)

0.3

Cigarette smoking (%)

101 (78.3%)

217 (81.6%)

0.489

DM (%)

21 (16.3%)

40 (14.8%)

0.766

HT (%)

64 (49.6%)

107 (39.6%)

0.083

DL (%)

24 (18.6%)

44 (16.4%)

0.572

History of cancer of other organs (%)

41 (32.0%)

75 (27.8%)

0.409

Stage of disease (0/I/II /III/IV)

36/30/39/14/10

25/25/39/87/94

 < 0.001

Treatment (ESD or EMR/OPE/CT and or RT/BSC)

48/64/10/7

21/157/74/18

 < 0.001

Lesion location (Ut/Mt/Lt) (%)

23/54/23

17/61/22

0.381

Macroscopic tumor type (0/1/2/3/4)

98/7/16/7/1

62/10/108/83/7

 

Histopathological grading (well/moderate/poor) (%)

22/73/5

17/61/22

0.143

Tumor size (mm)

29.8 ± 20.8

33.8 ± 33.8

 < 0.001

Cases of stenosis (%)

1 (4.8%)

61 (38.1%)

 < 0.001

Observation period (months)

63.7

34.6

 < 0.001

  1. Data are presented as mean ± standard deviation, n, or n (%)
  2. DM diabetes mellitus, HT hypertension, DL dyslipidemia, ESD endoscopic submucosal dissection, EMR endoscopic mucosal resection, OPE operation, CT computed tomography, RT radiation therapy, BSC best supportive care, Ut upper thoracic esophagus, Mt middle thoracic esophagus, Lt lower thoracic esophagus